MYMD、MDIA和LIFW均为上市前涨幅股

2024-04-09 20:48

Gainers: Acrivon Therapeutics (ACRV) +75% Announces $130 Million Private Placement Financing.
Laser Photonics (LASE) +66% Secures Order From L3Harris Technologies for LaserTower Marking & Engraving System.
MyMD Pharmaceuticals (MYMD) +35%.
Molecular Templates (MTEM) +25% Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism.
Rail Vision (RVSN) +21%.
Addex Therapeutics (ADXN) +20%.
Pineapple Financial (PAPL) +20%.
Vivos Therapeutics (VVOS) +22% files to sell 1.73M shares of common stock for holders.
Aterian (ATER) +19% Partners with Mercado Libre, Latin America’s Leading E-Commerce Platform
Anghami (ANGH) +14%.
MediaCo (MDIA) +11%.
MSP Recovery (LIFW) +11%.
AGM Group Holdings (AGMH) +10% Enters Strategic Partnership with AI Service Provider RDA to Construct AI Data Centers.
Shengfeng Development (SFWL) +7%.
Taysha Gene Therapies (TSHA) +7%.
Sasol (SSL) +7%.
Marti Technologies (MRT) +6%.

More on premarket gainers & stock